Five clinics will be participating in a Phase 3 Double Blind placebo controlled study for the treatment of Diabetic Neuropathy. Qualified participants will spend 8 - 10 hours a day for 12 to 15 consecutive days, for which they will be paid. Follow up evaluations immediately following and for 6 months after the procedure will be required.
Update: As of October 2007, we are not accepting any further study particpants. Check back in Spring 2008 for further news regarding the completion of the study.
"Advanced Magnetic Research Institute" and "AMRI" are Registered in U.S. Patent and Trademark Office
